Respiratory Function Tests
Respiratory Function Tests
Respiratory Function Tests (RFTs), or lung function tests, are painless breathing evaluations measuring how well your lungs take in air, move it in and out, and transfer oxygen to blood, using tools like spirometry (how fast you breathe out) and plethysmography (total lung capacity in a booth) to diagnose breathing issues, monitor lung diseases, and assess lung health before surgery. These tests provide crucial data for managing asthma, COPD, and other respiratory conditions.
Overall Objective: To understand the principles, methodologies, and clinical significance of various tests used to assess pulmonary function, differentiate between obstructive and restrictive lung diseases, and monitor disease progression.
Objective 1: Describe the principles and interpretation of spirometry, including FEV1, FVC, and FEV1/FVC ratio.
Spirometry is the most common and fundamental pulmonary function test. It measures how much air a person can inhale and exhale, and how quickly they can exhale it. It's an indispensable tool for diagnosing and managing a wide range of respiratory conditions.
A. Spirometry Basics
Definition and Purpose
Definition: Spirometry is a simple, non-invasive test that measures the volume and flow of air that can be inhaled and exhaled.
- Diagnose respiratory diseases (e.g., asthma, COPD).
- Monitor disease progression and response to treatment.
- Assess severity of lung impairment.
- Evaluate disability for legal or insurance purposes.
- Pre-operative assessment of respiratory risk.
How Spirometry is Performed (Forced Exhalation Maneuver)
- The patient takes the deepest breath possible (maximal inspiration) to reach Total Lung Capacity (TLC).
- Then, they forcefully and rapidly exhale all the air they can, for as long as they can (at least 6 seconds, or until no more air can be exhaled) into a mouthpiece connected to a spirometer.
- It requires good patient cooperation and effort to obtain reliable and reproducible results.
Parameters Measured
Spirometry primarily measures two key volumes, from which a crucial ratio is derived:
Forced Vital Capacity (FVC)
Total Volume Exhaled
Definition: The total volume of air exhaled during a maximal forced expiration, starting from a maximal inspiration.
Represents: Total "usable" air. Reflects overall size/elasticity of lungs and chest wall.
Normal Value: ~4-6 liters (varies by age/height).
FEV1
Volume in 1st Second
Definition: The volume of air exhaled in the first second of the FVC maneuver.
Represents: Speed/ease of expulsion. Indicator of airway patency/resistance.
Normal Value: 75-85% of FVC.
FEV1/FVC Ratio
The Critical Ratio
Definition: Ratio of FEV1 to FVC, expressed as percentage.
Represents: Most important parameter for differentiating obstructive vs. restrictive disease.
Normal Value: ≥ 70-75% (or ratio ≥ 0.70-0.75).
Flow-Volume Loops
Description: A graphical representation generated during spirometry that plots instantaneous expiratory flow rate (y-axis) against lung volume (x-axis).
A rapid rise to peak expiratory flow, followed by a linear decrease in flow as lung volume decreases, forming a triangular or "sail-like" shape. Inspiratory limb is a smooth, concave curve.
Characterized by a "scooped-out" or concave shape of the expiratory limb, reflecting significant airflow limitation. Peak flow may be reduced.
Characterized by a "witch's hat" appearance – smaller loop overall (reduced FVC) but with a relatively normal, preserved flow rate shape (proportional but scaled down).
Both inspiratory and expiratory limbs are flattened.
B. Interpretation of Spirometry Results
Interpretation involves comparing measured values to predicted normal values (based on age, sex, height, ethnicity).
Normal
- Ratio: ≥ 70-75%
- FEV1: ≥ 80% predicted
- FVC: ≥ 80% predicted
Suggests healthy lung function.
Obstructive
Example: COPD, Asthma
- Ratio: < 70-75% (KEY DIAGNOSTIC)
- FEV1: Reduced (< 80%)
- FVC: Normal or slightly reduced
- Loop: "Scooped-out"
Increased resistance makes exhalation difficult.
Restrictive
Example: Fibrosis, Scoliosis
- Ratio: Normal/Increased (≥ 70%)
- FEV1: Reduced (< 80%)
- FVC: Reduced (< 80%)
- Loop: "Witch's hat" (small)
Reduced compliance/volume; both reduced proportionally.
Severity Grading (e.g., COPD GOLD)
Based on FEV1 % predicted:
- Mild: ≥ 80%
- Moderate: 50-79%
- Severe: 30-49%
- Very Severe: < 30%
Bronchodilator Reversibility
Purpose: Differentiate Asthma vs. COPD.
Significant Reversibility: Increase in FEV1/FVC of >12% AND >200 mL.
- Asthma: Typically significant reversibility.
- COPD: Often less pronounced/consistent; obstruction is largely fixed.
Objective 2: Understand additional lung volumes and capacities measured by methods other than spirometry, particularly Residual Volume (RV) and Total Lung Capacity (TLC).
While spirometry is excellent for measuring dynamic lung function (how much air can be quickly moved), it has limitations. Specifically, it cannot measure volumes of air that cannot be exhaled from the lungs. This necessitates other techniques to determine the complete picture of lung volumes.
A. Limitations of Spirometry
Spirometry directly measures vital capacity (VC or FVC) and its components (IRV, TV, ERV). However, it cannot measure:
The volume of air remaining in the lungs after a maximal forced expiration.
The volume of air remaining in the lungs after a normal tidal expiration (ERV + RV).
The total volume of air in the lungs after a maximal inspiration (VC + RV, or FRC + IC).
These volumes are essential for diagnosing and characterizing certain lung conditions, particularly restrictive lung diseases (where TLC is reduced) and obstructive diseases with air trapping (where RV and TLC might be increased).
B. Methods for Measuring RV, FRC, and TLC
Since RV, FRC, and TLC all include the residual volume, which cannot be exhaled, specialized techniques are required to measure them.
1. Helium Dilution Method
Inert gas dilution. If a known quantity of a tracer gas (helium, insoluble in blood) is introduced into a closed system, it distributes throughout the available lung volume until equilibrium is reached. The extent of dilution is used to calculate the unknown volume.
- Patient connected to spirometer with known volume/concentration of helium (C1).
- Patient breathes normally (tidal breathing) from closed system. Exhales to FRC, then circuit opens.
- Helium mixes with air in lungs (FRC volume).
- Breathing continues until equilibrium is reached (C2). Usually 5-7 minutes.
- Patient performs maximal expiration (ERV) and maximal inspiration (VC).
FRC = ( (Vspirometer * C1) / C2 ) - Vspirometer
Once FRC is known: TLC = FRC + IC and RV = FRC - ERV.
Assumes free mixing. In severe obstruction/air trapping (e.g., emphysema), trapped air may not equilibrate, leading to underestimation of FRC and TLC.
2. Nitrogen Washout Method
Uses inert gas (nitrogen) but measures washout. Lungs are normally ~80% nitrogen. Breathing 100% O2 washes nitrogen out, which is collected.
- Patient exhales to FRC.
- Breathes 100% oxygen from spirometer.
- Exhaled air (containing lung nitrogen) is collected and analyzed.
- Continues until exhaled nitrogen drops to < 1.5% (approx 7 mins).
Similar to helium dilution, tends to underestimate FRC/TLC in severe obstruction due to poorly ventilated trapped air.
3. Body Plethysmography (Body Box)
Generally considered the most accurate method. Uses Boyle's Law (P1V1 = P2V2).
- Patient sits in airtight "body box".
- Pants against a closed shutter at end of normal expiration (FRC).
- Chest expansion decreases box volume -> increases box pressure.
- Simultaneously lung volume increases -> lung pressure decreases.
- Transducers measure mouth pressure and box pressure changes.
Calculates thoracic gas volume (TGV). Unlike dilution methods, it measures all compressible gas within the thorax (including trapped air), making it more accurate for obstructive diseases.
Claustrophobia, equipment cost.
C. Clinical Significance of RV and TLC
Increased RV & TLC
Indicates: Hyperinflation and air trapping.
Clinical Relevance: Hallmark of Obstructive Lung Diseases (Emphysema, Asthma).
- Emphysema: Loss of elastic recoil = difficult to exhale = increased RV/FRC.
- Asthma/Bronchitis: Airway narrowing traps air.
RV/TLC Ratio: An increased ratio (>30%) is a strong indicator of air trapping.
Decreased RV & TLC
Indicates: Reduced lung volumes.
Clinical Relevance: Defining characteristic of Restrictive Lung Diseases.
- Intrinsic: Fibrosis, Sarcoidosis (stiff tissue).
- Extrinsic: Obesity, Neuromuscular disease, Scoliosis (restricted expansion).
Differentiation: A reduced TLC (<80% predicted) is the definitive criterion for restrictive disease.
Objective 3: Explain the principles and clinical utility of Diffusing Capacity of the Lung for Carbon Monoxide (DLCO/TLCO).
The diffusing capacity of the lung (DLCO), also sometimes referred to as Transfer factor for Carbon Monoxide (TLCO), measures the efficiency of gas exchange across the alveolar-capillary membrane. It assesses the integrity and function of the primary site where oxygen enters the blood and carbon dioxide leaves it.
A. DLCO Basics
DLCO is the rate at which carbon monoxide (CO) is absorbed from the alveoli into the pulmonary capillary blood per unit of driving pressure (partial pressure gradient) for CO. Essentially, it quantifies the ability of the lungs to transfer gas from the inhaled air into the red blood cells.
Principle:
Used because of its very high affinity for hemoglobin (200-250x greater than oxygen). This ensures that almost all CO that diffuses into the blood binds to hemoglobin, maintaining a near-zero partial pressure in plasma. Thus, alveolar partial pressure (PACO) becomes the primary driving force.
Inhaled mixture contains low concentration CO (0.3%), an inert tracer gas (helium/methane for measuring alveolar volume), oxygen (21%), and nitrogen.
Calculated by measuring how much CO disappears from the inhaled gas (after correcting for alveolar volume).
Correcting Factors:
- Hemoglobin Concentration: Since CO binds to Hb, the amount of available Hb directly affects uptake. DLCO is corrected (upwards for anemia, downwards for polycythemia) to reflect normal Hb levels.
- Alveolar Volume (VA): Total surface area is proportional to lung volume. DLCO/VA (KCO) normalizes diffusing capacity to lung volume, differentiating reduced DLCO due to small lungs vs. actual membrane impairment.
B. Factors Affecting DLCO
The diffusing capacity is determined by properties of the alveolar-capillary membrane and the pulmonary circulation.
Increased: Exercise, Polycythemia.
Decreased: Emphysema (destruction of alveolar walls), Pneumonectomy/Lobectomy.
Decreased DLCO: Conditions increasing barrier thickness.
- Pulmonary Fibrosis / ILD.
- Pulmonary Edema (fluid accumulation).
- Asbestosis, Sarcoidosis.
Decreased DLCO: Anemia (fewer binding sites).
Increased DLCO: Polycythemia (increased RBC mass).
Decreased: Pulmonary Hypertension, Pulmonary Embolism.
Increased: Congestive Heart Failure, Cardiac Shunts (L to R), Exercise.
C. Interpretation of DLCO Results
Results are compared to predicted values. < 80% predicted is typically considered reduced.
Reduced DLCO
- Emphysema: Key differentiator from asthma.
- Pneumonectomy.
- Fibrosis / ILDs: Correlates with severity.
- Pulmonary Edema.
- Pulmonary Hypertension: Early sign.
- Pulmonary Embolism.
- Anemia (uncorrected).
- Drug toxicity (Amiodarone).
Normal DLCO
- Asthma: Primarily airway obstruction, membrane intact. (Key vs Emphysema).
- Chronic Bronchitis: Usually normal unless emphysema present.
- Neuromuscular / Chest Wall: Membrane unaffected.
Increased DLCO
- Polycythemia: Increased Hb.
- Congestive Heart Failure: Increased capillary volume.
- Pulmonary Hemorrhage: CO binds to RBCs in alveoli.
- Exercise: Capillary recruitment.
D. Clinical Utility
- Obstructive: Distinguishes Emphysema (Low DLCO) vs. Asthma/Bronchitis (Normal DLCO).
- Restrictive: Distinguishes ILD (Low DLCO) vs. Neuromuscular/Chest Wall (Normal DLCO).
- Severity/Prognosis: Monitors progression in ILD/Emphysema.
- Early Detection: Drug toxicity may show low DLCO before spirometry changes.
- Pre-op: Surgical risk assessment.
- Vascular Disease: Suggests PH or emboli if parenchyma is normal.
Objective 4: Discuss the role of Arterial Blood Gas (ABG) analysis in assessing respiratory and acid-base status.
Arterial Blood Gas (ABG) analysis is a vital diagnostic tool that measures the partial pressures of oxygen (PaO2) and carbon dioxide (PaCO2) in arterial blood, as well as blood pH and bicarbonate (HCO3-) concentration. It provides a real-time snapshot of the patient's oxygenation, ventilation, and acid-base balance.
A. ABG Components
The primary parameters measured or calculated from an ABG sample include:
Definition: Measure of acidity/alkalinity (H+ concentration).
Significance: Acid-base imbalance. Acidosis (< 7.35), Alkalosis (> 7.45).
Definition: Pressure of dissolved oxygen in arterial blood.
Significance: Oxygenation status. < 80 mmHg = Hypoxemia.
Definition: Pressure of dissolved CO2. Controlled by ventilation.
- > 45 mmHg: Hypoventilation (Resp. Acidosis)
- < 35 mmHg: Hyperventilation (Resp. Alkalosis)
Definition: Bicarbonate (Metabolic component).
- < 22 mEq/L: Metabolic Acidosis
- > 26 mEq/L: Metabolic Alkalosis
B. Interpretation of ABG Results
Interpreting ABGs involves a systematic approach to identify the primary acid-base disturbance, assess for compensation, and evaluate oxygenation and ventilation.
1. Acid-Base Disturbances
| Step | Logic |
|---|---|
| Step 1: pH | Is it acidic (< 7.35), alkaline (> 7.45), or normal? |
| Step 2: PaCO2 (Resp) |
Acidosis + High PaCO2 = Respiratory Acidosis Alkalosis + Low PaCO2 = Respiratory Alkalosis |
| Step 3: HCO3- (Metabolic) |
Acidosis + Low HCO3- = Metabolic Acidosis Alkalosis + High HCO3- = Metabolic Alkalosis |
2. Compensation
Lungs adjust CO2 to correct metabolic issues.
- Metabolic Acidosis: Hyperventilation (blow off CO2).
- Metabolic Alkalosis: Hypoventilation (retain CO2).
Kidneys adjust HCO3- to correct respiratory issues.
- Resp Acidosis: Retain HCO3-, excrete H+.
- Resp Alkalosis: Excrete HCO3-, retain H+.
Partial vs. Full: If pH is abnormal but moving towards normal = Partial. If pH is back in range = Full.
3. Oxygenation & Ventilation Status
- Mild: 60-79 mmHg
- Moderate: 40-59 mmHg
- Severe: < 40 mmHg
- Hypoventilation: PaCO2 > 45 mmHg (Acidosis). e.g., COPD, Opioids.
- Hyperventilation: PaCO2 < 35 mmHg (Alkalosis). e.g., Anxiety, PE.
C. Clinical Utility
Diagnosing Respiratory Failure
Oxygenation problem.
- PaO2: Low
- PaCO2: Normal/Low
- Example: Pneumonia, ARDS, Pulmonary Edema.
Ventilatory problem (CO2 retention).
- PaO2: Low
- PaCO2: High
- Example: COPD exacerbation, Opioid overdose.
Monitoring Critically Ill: Essential for sepsis, DKA, renal failure.
Guiding Therapy: Determines oxygen needs and helps adjust mechanical ventilator settings (rate/tidal volume) to normalize PaCO2.
Objective 5: Briefly mention other specialized respiratory function tests.
Beyond the foundational tests we've discussed, several other specialized pulmonary function tests exist. These tests often target specific clinical questions or provide more nuanced information about lung mechanics, control of breathing, or airway responsiveness.
A. Airway Responsiveness Testing (Bronchial Challenge Tests)
Purpose & Method
Purpose: To identify or confirm airway hyperresponsiveness, a hallmark feature of asthma, even when baseline spirometry is normal.
Method: The patient inhales progressively increasing doses of a bronchoconstricting agent (most commonly methacholine, a cholinergic agonist) or undergoes physical challenges (e.g., exercise, hyperventilation of cold, dry air). Spirometry (FEV1) is measured after each dose.
A significant drop in FEV1 (typically ≥20%) at a low dose of the provocative agent indicates airway hyperresponsiveness. The dose that causes a 20% drop (PC20) is inversely related to the degree of hyperresponsiveness.
- Diagnosis of asthma when routine tests are inconclusive.
- Evaluating occupational asthma.
- Monitoring treatment effectiveness.
- Severe airflow obstruction (FEV1 < 60-70% predicted).
- Recent myocardial infarction or stroke.
- Uncontrolled hypertension.
- Aortic aneurysm.
- Pregnancy.
B & C. Exercise Testing
Six-Minute Walk Test (6MWT)
Functional Capacity
Purpose: Submaximal test measuring distance walked in 6 minutes on a flat surface. Assesses integrated cardiorespiratory/musculoskeletal function.
Method: Self-paced walking. SpO2 and heart rate monitored.
Interpretation: Distance (6MWD) compared to predicted. Desaturation is highly significant.
Utility: Prognosis in COPD/ILD/Heart Failure, monitoring rehab, assessing O2 needs.
Cardiopulmonary Exercise Testing (CPET)
Diagnostic / Maximal
Purpose: Comprehensive evaluation of responses to increasing physical demand. Differentiates cardiac vs. pulmonary causes.
Method: Treadmill/Cycle with continuous ECG, BP, SpO2, and exhaled gas analysis (VO2, VCO2).
Interpretation: Analyzes Peak VO2 (VO2max), anaerobic threshold, ventilatory efficiency.
Utility: Unexplained dyspnea, pre-op risk stratification, disability assessment.
D. Inspiratory and Expiratory Muscle Strength (MIP/MEP)
Purpose: To assess the strength of the respiratory muscles.
- Maximal Inspiratory Pressure (MIP or PImax): Measured at residual volume (RV) by having the patient generate a maximal inspiratory effort against an occluded airway.
- Maximal Expiratory Pressure (MEP or PEmax): Measured at total lung capacity (TLC) by having the patient generate a maximal expiratory effort against an occluded airway.
- Diagnosing neuromuscular diseases (ALS, Myasthenia Gravis).
- Assessing weaning from mechanical ventilation.
- Evaluating unexplained dyspnea/hypoventilation.
E. Functional Imaging (HRCT & V/Q)
While not "pulmonary function tests" in the classical sense, these provide critical functional information:
Provides detailed anatomical imaging. Used to visualize emphysema, fibrosis, bronchiectasis, and air trapping. Aids in correlating functional deficits (from PFTs) with structural changes.
Uses radioactive tracers to assess regional ventilation (air movement) and perfusion (blood flow). Primarily used for diagnosing Pulmonary Embolism (mismatch) and pre-op assessment for lung resections.
These specialized tests, when used judiciously, complement the standard pulmonary function tests to provide a comprehensive evaluation of the respiratory system, leading to more accurate diagnoses and tailored management plans.
Respiratory Function Tests Exam
Test your knowledge with these 32 questions.
Respiratory Function Tests
Question 1/32
Exam Complete!
Here are your results, .
Your Score
29/32
91%